Rate the Article: Studies on Drug Delivery Efficacy of Silver Nanoparticles Synthesized using Human Serum Albumin as Tamoxifen Carriers in MCF-7 Cell Line, IJSR, Call for Papers, Online Journal
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064

Downloads: 136 | Views: 367

Research Paper | Biology | India | Volume 6 Issue 1, January 2017 | Rating: 6.6 / 10


Studies on Drug Delivery Efficacy of Silver Nanoparticles Synthesized using Human Serum Albumin as Tamoxifen Carriers in MCF-7 Cell Line

V. Pradeepa, T. Sriram, M. Sujatha


Abstract: A simple and convenient method is synthesis of silver Nanoparticles (AgNps) in a foam matrix using the protein Human serum albumin (HSA) is reported. HAS is an excellent foaming agent and by virtue of its zwitter ionic character at the protein isoelectric point, may be used to bind to cationic silver (Ag+) ions in the foam. The metal ions in the foam are thereafter reduced in situ to yield silver Nanoparticles. The HAS molecules coat and stabilize the Nanoparticles thus eliminating the necessity of employing an additional stabilizing agent in the experimental procedure. The synthesized Nanoparticles where characterized by UV-visible spectroscopy, X-ray diffraction (XRD), Scanning electron microcopy (SEM), energy-dispersive X-ray spectrometry (EDAX) and Fourier-transform infrared spectroscopy (FTI) with silver Nanoparticles of 20-30nm were obtained invitro cytotoxic studies revealed that the silver Nanoparticles shows Significant growth inhibition in dose dependent manner.


Keywords: Silver Nanoparticles, Human Serum Albumin, MCF-7, Cancer, MTT Assay, FTIR


Edition: Volume 6 Issue 1, January 2017,


Pages: 1881 - 1888



Rate this Article


Select Rating (Lowest: 1, Highest: 10)

5

Your Comments (Only high quality comments will be accepted.)

Characters: 0

Your Full Name:


Your Valid Email Address:


Verification Code will appear in 2 Seconds ... Wait

Top